InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the detailed record of transactions filed by Doody Kevin, Directeur Médical. Insider active across 1 company, notably INVO Bioscience, Inc.. Cumulatively, 2 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €158k. Activity tracked since 15 January 2022. The latest transaction was filed on 1 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Doody Kevin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
177,306 股@ US$0.95100.0% 占其流量Common StockSEC:0001493152-22-015904:0
标准退出：2022年8月30日 (T+90)
7,480 股0Common StockSEC:0001493152-22-001535:0
2 条申报中的 2 条
About Doody Kevin
Kevin Doody serves as the Medical Director of INVO Bioscience, Inc. He oversees the medical and clinical aspects of the company. His expertise is crucial in ensuring compliance with medical standards and guiding research and development initiatives.
